Global patent searches, Freedom to Operate (FTO) clearance, patent & technology valuation, ingredient intelligence, and 10 regulatory toxicology disciplines.
Global patent sweeps across USPTO, EPO, WIPO, JPO, KIPO, and CNIPA to clear commercial launch pathways and challenge prior art.
Identify global prior art to evaluate whether a technical invention meets the requirements of novelty and non-obviousness before filing.
Uncover obscure prior art and prior-use evidence to challenge the validity of asserted patent claims in litigation or opposition proceedings.
Clear commercialization pathways by identifying active patents and pending claims that might be infringed by product launch.
Identify out-licensing partners, in-licensing technology candidates, and market monetization paths for patented assets.
Formulate robust patent specifications, claim sets, and technical disclosures engineered for multi-jurisdictional patent prosecution.
Understanding patent value enables decision makers to focus R&D budgeting, negotiate M&A transactions, and support tax/financial reporting.
Our clients retain us to help them understand the value of their patents, other forms of intellectual property and intangible assets. Understanding patent value enables decision makers to focus research and development and other capital budgeting efforts, plan and negotiate transactions, strategize in anticipation of, or within, litigation, and address financial and tax reporting requirements.
Ingredient intelligence, sustainability analysis, regulatory compliance, and 10 regulatory toxicology disciplines.
Staying ahead of competition and sustainability trends requires access to the latest insights into ingredients and their science. Our Ingredient Intelligence services are designed to provide a 360 degree view of patents, scientific literature, clinical studies, GRAS compliance, product usage, suppliers and much more, allowing us to help customers identify emerging technologies, design better products, and support your sustainability goals.
Evaluate new ingredients and identify trends to help meet your objectives - better flavours, cleaner products, sustainable practices.
Assess and optimize your existing processes to minimize environmental impacts while improving manufacturing efficiency.
Guide your selection of alternative materials that reduce environmental impacts without compromising product quality.
Our services help you create innovative and environmentally friendly products. With ever changing guidelines and regulations on using sustainable and cleaner materials, reducing carbon footprint, and managing consumer expectation, we help our customers in identifying better solutions and innovations. This helps our customers meet their sustainable product goals, deploy improvements, and partner with leading players thereby ensuring compliance with environmental regulations.
Design products that use resources efficiently, minimizing their environmental footprint.
Streamline material selection and manufacturing practices to reduce waste and energy consumption.
Ensure products remain sustainable from production through end-of-life recycling and reusability.
Implement Green Chemistry's prevention principle by designing processes that minimize waste from the outset.
Ten regulatory toxicology disciplines under one scientific standard: REACH/CLP, biocides, cosmetics, pharma, NAMs, endocrine and environmental risk assessment.
Registration, evaluation and classification. Technical & CSR dossiers, read-across & WoE reasoning holding up under ECHA scrutiny.
Active substance approvals and renewals under EU BPR, endocrine disruptor assessment (EFSA/ECHA), and technical equivalence.
CPSRs Part A + B, SCCS-style reviews of finished products, Margin of Safety (MoS) calculations, and claims defence.
PDE/OEL monographs, nitrosamine risk assessments, extractables & leachables (E&L), and ISO 10993 biocompatibility.
PBT/vPvB evaluation, fate & exposure modelling (PEC/PNEC), and ecotoxicology weight-of-evidence under ECHA & EFSA guidance.
AOP-anchored read-across, in silico predictions (QSAR), and exposure-led NGRA integrating in vitro evidence.
ED screening, ECHA/EFSA 2018 guidance application, WoE evaluation across EATS modalities, and Mode-of-Action narratives.
Systematic literature reviews (PRISMA, OHAT), evidence maps, and targeted dossiers engineered to satisfy scientific peer review.
Independent CRO qualification, scientific protocol review, in-life monitoring, and OECD GLP / TG report auditing.
In silico screening tools, knowledge graphs, and ML-augmented read-across applied to real regulatory questions.
Connect with our IP strategists, valuation specialists, and certified toxicologists to discuss your technical milestone.
Connect with an IP Lead